Viruses and thrombocytopenia

Reyhaneh Rasizadeh; Fatemeh Ebrahimi; Atefeh Zamani Kermanshahi; Amin Daei Sorkhabi; Aila Sarkesh; Javid Sadri Nahand; Hossein Bannazadeh Baghi

doi:10.1016/j.heliyon.2024.e27844

Viruses and thrombocytopenia

Heliyon. 2024 Mar 16;10(6):e27844. doi: 10.1016/j.heliyon.2024.e27844. eCollection 2024 Mar 30.

Authors

Reyhaneh Rasizadeh^{1

2

3}, Fatemeh Ebrahimi², Atefeh Zamani Kermanshahi², Amin Daei Sorkhabi^{1

4}, Aila Sarkesh^{1

4}, Javid Sadri Nahand^{2

5}, Hossein Bannazadeh Baghi^{1

2

5}

Affiliations

¹ Immunology Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran.
² Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
⁴ Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
⁵ Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Abstract

Thrombocytopenia, characterized by a decrease in platelet count, is a multifaceted clinical manifestation that can arise from various underlying causes. This review delves into the intriguing nexus between viruses and thrombocytopenia, shedding light on intricate pathophysiological mechanisms and highlighting the pivotal role of platelets in viral infections. The review further navigates the landscape of thrombocytopenia in relation to specific viruses, and sheds light on the diverse mechanisms through which hepatitis C virus (HCV), measles virus, parvovirus B19, and other viral agents contribute to platelet depletion. As we gain deeper insights into these interactions, we move closer to elucidating potential therapeutic avenues and preventive strategies for managing thrombocytopenia in the context of viral infections.

Keywords: Coagulation; Inflammation; Platelets; Thrombocytopenia; Thrombosis.

Publication types

Review